Literature DB >> 6754139

Concentrations of apolipoproteins B, C-I, C-II, C-III and E in sera from normal men and their relation to serum lipoprotein levels.

L A Carlson, L Holmquist.   

Abstract

The concentrations of apolipoproteins B, C-I, C-II, C-III and E (by enzyme immunoassay), and cholesterol, triglycerides and phospholipids both in while serum and in serum very low (VLDL), low (LDL) and high (HDL) density lipoproteins, HDL2 and HDL3, were determined in sera from 29 randomly selected normolipidemic men, age 40-60 years, in Stockholm, Mean values, +/- SD, were for, apolipoprotein B, 720 +/- 162; C-I, 63 +/- 14; C-II, 27 +/- 11; C-III, 125 +/- 57; and for E, 25 +/- 6 mg/l. A skewness to the right of the distributions was found for apolipoproteins B and C-II and for serum triglycerides and VLDL lipids. The relations between the different variables were studied by linear correlation analysis. Several significant correlations existed between the lipoprotein levels. Apolipoprotein C-I, C-II and C-III were significantly correlated with each other, whereas neither apolipoprotein B nor apolipoprotein E was correlated with any other apolipoprotein. The following significant, positive correlations existed between the apolipoproteins and total serum lipids and/or lipids of lipoprotein density classes: apolipoprotein B with serum cholesterol and LDL lipids, apolipoprotein C-I with HDL3 cholesterol, apolipoprotein C-II with serum triglycerides and VLDL lipids, apolipoprotein C-III with serum cholesterol and phospholipids. Apolipoprotein E showed no correlation with either serum lipids or lipoproteins.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6754139     DOI: 10.1016/0009-8981(82)90384-9

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  3 in total

1.  Constitutive inhibition of plasma CETP by apolipoprotein C1 is blunted in dyslipidemic patients with coronary artery disease.

Authors:  Xavier Pillois; Thomas Gautier; Benjamin Bouillet; Jean-Paul Pais de Barros; Aline Jeannin; Bruno Vergès; Jacques Bonnet; Laurent Lagrost
Journal:  J Lipid Res       Date:  2012-04-02       Impact factor: 5.922

2.  Effect of simvastatin on plasma lipids, apolipoproteins and lipoprotein particles in patients with primary hypercholesterolaemia.

Authors:  J M Bard; G Luc; P Douste-Blazy; P Drouin; O Ziegler; B Jacotot; C Dachet; J L De Gennes; J C Fruchart
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

3.  Feasibility of ApoC1 serum levels as tumor biomarker in glioblastoma patients: a pilot study.

Authors:  Michelle Hilbert; Peter Kuzman; Wolf C Mueller; Jürgen Meixensberger; Ulf Nestler
Journal:  Sci Rep       Date:  2022-10-10       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.